|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 128.09 USD | +1.58% |
|
-9.87% | -5.94% |
| 13/02 | UBS Adjusts Xylem Price Target to $155 From $168, Maintains Buy Rating | MT |
| 12/02 | Oppenheimer Adjusts Xylem Price Target to $165 From $170, Maintains Outperform Rating | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | $158.41 | +23.67% | 17 | |||||
| Average | 158.41 | +23.67% | 17 | ||||||
| Weighted average by Cap. | 158.41 | +23.67% | 17 |
- Stock Market
- Equities
- XYL Stock
- Sector Xylem Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition